The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months’ follow-up with computed tomography
Authors:Sayama Christina (Switzerland, Europe)Hadley Caroline (United States, Americas)Monaco Gina N (United States, Americas)Sen Anish (United States, Americas)Brayton Alison
+ 6 more
Briceno ValentinaTran Brandon H (Switzerland, Europe)Ryan Sheila L (United States, Americas)Luerssen Thomas GFulkerson Daniel (United States, Americas)Jea Andrew
Source: Journal of Neurosurgery: Pediatrics PED, 16(1), 14-20.
Date: April 10, 2015Please create a free account or log in to view this item
Registration is free, quick and easy. Simply register and complete your profile to get access. If you already have an account with the ISPN Library or ISPN Guide, login below.
Create an account
Login
Register
Log in using your ISPN Guide or ISPN Library credentials
Not yet registered? Join now











